Elekta is dedicated to bringing oncology and neuroscience advancements to clinics around the world. Recently the company introduced Elekta Healthcare Analytics, a solution for accelerating data analysis to improve clinical, operational and financial decision-making. Last year in Toronto, Elekta and The Michener Institute for Applied Health Sciences announced that they are enhancing the simulation experiences for the next generation of radiation therapists.
CATA President John Reid said, "We are honoured that such an innovative and pioneering company has turned to CATAAlliance to build relationships and collaborate with other companies advocating for improvement to Canada's innovation climate."
Rui Lopes, Director of Business Marketing at Elekta added, "We recognize CATA as a leader in promoting innovation, business networking, research, and forums in Canada's technology sectors. Elekta is proud to join the Canadian Advanced Technology Alliance."
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.